EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs) in advanced NSCLC patients

Research Area: Year: 2008
Type of Publication: In Proceedings
Authors:
  • Crinò, L.
  • Pistola, L.
  • Bianconi, Fortunato
  • Chiari, R.
  • Meacci, M.
  • Collella, R.
  • Giuffrida, D.
  • R. Tofanetti, F.
  • Flacco, A.
  • Ludovini, V.
Editor: Journal of Clinical Oncology
Organization: ASCO
BibTex: